1.
Schreiber R, Crane K, Patel J. Efficacy and Tolerability of Tazarotene Foam 0.1% Across Age, Gender, and Race: An Integrated Review of Two Phase III Trials. J of Skin [Internet]. 2017Oct.27 [cited 2020Nov.29];1(3.1):s50. Available from: https://jofskin.org/index.php/skin/article/view/176